✦ LIBER ✦

Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells

✍ Scribed by C.L. Malmendier; J-F. Lontie; J.P. Sculier; D.Y. Dubois

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe intrahepatic cholestasis in patie

✍ Mitchel Hoffman; Abraham Mittelman; Brad Dworkin; William Rosenthal; Deborah Ben 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 1014 KB

Levels of soluble interleukin-2 receptor

✍ Elisabeth Paietta; David L. Nelson; Janet Andersen; Janice P. Dutcher; Peter H. 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 428 KB

Evaluation of natural killer and lymphok

✍ J. Walewski; E. Paietta; J. Dutcher; P. H. Wiernik 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 489 KB

Recombinant interleukin-2 and lymphokine

✍ Claudio Fortis; Elisabetta Ferrero; Carlo Besana; Mauro Biffi; Silvia Heltai; La 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 735 KB

Recombinant interleukin-2 and lymphokine

✍ Claudio Fortis; Elisabetta Ferrero; Mauro Biffi; Silvia Heltai; Carlo Besana; Er 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 689 KB

Tolerance and effectiveness of recombina

✍ Stahel, R.A.; Sculier, J.P.; Jost, L.M.; Delforge, A.; Bron, D.; Gmür, J.; Oelz, 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 725 KB